Mallinckrodt Public Limited Company Current Ratio 2012-2018 | MNK

Mallinckrodt Public Limited Company current ratio from 2012 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Mallinckrodt Public Limited Company Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $2.04B $0.92B 2.21
2018-06-30 $2.01B $0.89B 2.27
2018-03-31 $2.31B $1.10B 2.10
2017-12-31 $2.29B $1.05B 2.18
2017-09-30 $1.45B $1.05B 1.38
2017-06-30 $1.44B $1.36B 1.06
2017-03-31 $1.45B $1.04B 1.40
2016-12-31 $1.57B $1.31B 1.20
2016-09-30 $0.00B $0.00B 0.00
2016-06-30 $1.63B $0.97B 1.68
2016-03-31 $1.55B $0.89B 1.73
2015-12-31 $1.63B $0.89B 1.83
2015-09-30 $1.85B $0.93B 1.99
2015-06-30 $1.54B $0.76B 2.03
2015-03-31 $2.22B $0.78B 2.86
2014-12-31 $2.07B $0.77B 2.70
2014-09-30 $2.07B $0.91B 2.29
2014-06-30 $1.65B $0.64B 2.58
2014-03-31 $1.63B $0.63B 2.61
2013-12-31 $1.41B $0.55B 2.54
2013-09-30 $1.39B $0.60B 2.31
2013-06-30 $1.15B $0.48B 2.38
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.00B 0.00
2012-09-30 $0.88B $0.40B 2.22
2012-06-30 $0.00B $0.00B 0.00
2011-09-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.817B $3.222B
Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt Plc. is based in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $46.906B 8.33
Teva Pharmaceutical Industries (TEVA) Israel $18.283B 6.31
Mylan (MYL) United Kingdom $16.418B 6.76
Bausch Health Cos (BHC) Canada $8.901B 6.44
Dr Reddy's Laboratories (RDY) India $5.974B 23.83
Supernus Pharmaceuticals (SUPN) United States $2.043B 19.36
Amphastar Pharmaceuticals (AMPH) United States $1.124B 121.90
Homology Medicines (FIXX) United States $0.916B 0.00
CymaBay Therapeutics (CBAY) United States $0.591B 0.00
Assembly Biosciences (ASMB) United States $0.583B 0.00
Akorn (AKRX) United States $0.557B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.414B 0.00
Voyager Therapeutics (VYGR) United States $0.349B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.288B 0.00
Sol-Gel Technologies (SLGL) Israel $0.127B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.092B 0.00
Teligent (TLGT) United States $0.087B 0.00
Acasti Pharma (ACST) Canada $0.071B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Evoke Pharma (EVOK) United States $0.053B 0.00
Agile Therapeutics (AGRX) United States $0.037B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.017B 0.00
Aevi Genomic Medicine (GNMX) United States $0.015B 0.00